Trials / Completed
CompletedNCT02893241
Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting
Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting: a Multicenter, Prospective, Non-interventional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,013 (actual)
- Sponsor
- Ratiopharm GmbH · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a national, multicentre, prospective, open, two-arm, non-interventional study with hospitalized patients, who are treated routinely with cafedrine/theodrenaline or ephedrine after occurrence of perioperative hypotension, wherein the patients are assigned to a treatment arm based on the department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cafedrine/theodrenaline | |
| DRUG | Ephedrine |
Timeline
- Start date
- 2016-04-30
- Primary completion
- 2017-12-31
- Completion
- 2017-12-31
- First posted
- 2016-09-08
- Last updated
- 2021-11-09
Locations
75 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02893241. Inclusion in this directory is not an endorsement.